Physician profile
Tamara Wright
NPI 1710056155
$1,215.32
in general payments reported to CMS, 2019-2025
21 companies · $182 in 2025
The $182 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $200 · 2020: $93.44 · 2021: $210 · 2022: $145 · 2023: $202 · 2024: $183 · 2025: $182.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $567.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $290.71 | 2019-2025 | Biktarvy |
| Viiv Healthcare Company | $160.29 | 2019-2023 | Dovato |
| Sanofi Pasteur INC. | $98.49 | 2023-2025 | |
| Astrazeneca Pharmaceuticals Lp | $82.26 | 2019-2024 | |
| Abbott Laboratories | $81.58 | 2021-2023 | Freestyle Libre 3 |
| Dexcom, INC. | $66.03 | 2021-2024 | Dexcom G6 Transmitter |
| Merck Sharp & Dohme LLC | $63.32 | 2022-2024 | Pifeltro, Delstrigo, Gardasil 9 |
| Lilly USA, LLC | $58.99 | 2020-2022 | |
| Sunovion Pharmaceuticals INC. | $48.87 | 2021 | |
| Averitas Pharma INC. | $40.83 | 2025 | Qutenza |
| Insulet Corporation | $29.56 | 2025 | Omnipod |
| Abbvie INC. | $27.50 | 2022 | |
| Optinose US, INC. | $25.28 | 2025 | |
| Vbi Vaccine (Delaware) INC. | $24.52 | 2023 | Prehevbrio |
| Novartis Pharmaceuticals Corporation | $24.25 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $22.93 | 2025 | Voquezna |
| Alkermes, INC. | $15.65 | 2025 | Aristada, Lybalvi |
| Ibsa Pharma INC. | $14.58 | 2019 | |
| Glaxosmithkline, LLC. | $14.45 | 2020 | |
| Kyowa Kirin, INC. | $12.96 | 2023 | Crysvita |
| Otsuka America Pharmaceutical, INC. | $12.27 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tamara Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.